3.0.0 867 2023-01-11T13:25:00Z 2023-01-11T13:25:00Z Senate S S 2013-05-06 113 ssfi00 Finance Committee Senate Standing Referred to 2013-05-06T22:33:12Z Generic Drug Pricing Fairness Act 113 4437 HR 2014-04-11 Referred to the Subcommittee on Health. Related bill CRS 2013-05-06 ssfi00 Finance Committee Senate Read twice and referred to the Committee on Finance. IntroReferral 2013-05-06 Introduced in Senate IntroReferral 10000 9 Library of Congress P000590 Sen. Pryor, Mark L. [D-AR] Mark Pryor D AR Lunsford N M000934 Sen. Moran, Jerry [R-KS] Jerry Moran R KS 2013-05-06 True W000437 Sen. Wicker, Roger F. [R-MS] Roger Wicker R MS F. 2013-05-06 True B001236 Sen. Boozman, John [R-AR] John Boozman R AR 2013-05-06 True J000177 Sen. Johnson, Tim [D-SD] TIM JOHNSON D SD 2013-05-08 False C000567 Sen. Cochran, Thad [R-MS] Thad Cochran R MS 2013-05-08 False Health Accounting and auditing Health information and medical records Medicare Prescription drugs Public contracts and procurement Health 00 2013-05-06 Introduced in Senate 2013-05-17T19:51:07Z Medicare Prescription Drug Program Integrity and Transparency Act of 2013 - Amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act to require each contract entered into with a prescription drug plan (PDP) sponsor with respect to a PDP the sponsor offers to prohibit the PDP from entering into a contract with any pharmacy benefits manager (PBM) to manage the prescription drug coverage provided under such plan, or to control the costs of the prescription drug coverage under it, unless the manager satisfies specified PBM audit and disclosure requirements.

Requires a PBM to provide: (1) a particular aggregate average reimbursement rate for generics or a maximum average discount off of an accepted pharmaceutical pricing benchmark for multi-source generics as a whole ("generic effective rate"), and (2) a process for the generic effective rate to be appealed.

Revises requirements for contracts with PDP sponsors to require that the PDP sponsor or a subcontractor of the sponsor disclose to a pharmacy, at the time when a contract is offered and at least once every seven days, the methodology and actual per unit reimbursement amount for each covered drug for each contracted pharmacy.

]]> Medicare Prescription Drug Program Integrity and Transparency Act of 2013 Display Title Medicare Prescription Drug Program Integrity and Transparency Act of 2013 Official Title as Introduced A bill to amend title XVIII of the Social Security Act to provide for pharmacy benefits manager standards under the Medicare prescription drug program, to establish basic audit standards of pharmacies, to further transparency of payment methodology to pharmacies, and to provide for recoupment returns to Medicare. Introduced in Senate IS Short Titles as Introduced Medicare Prescription Drug Program Integrity and Transparency Act of 2013 Introduced in Senate 2013-05-06T04:00:00Z https://www.govinfo.gov/content/pkg/BILLS-113s867is/xml/BILLS-113s867is.xml 2013-05-06 Read twice and referred to the Committee on Finance. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.